Privium Fund Management (UK)’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,860
| Closed | -$274K | – | 177 |
|
|
2024
Q1 | $274K | Buy |
+5,860
| New | +$274K | 0.14% | 74 |
|
|
2023
Q3 | – | Sell |
-5,860
| Closed | -$94.9K | – | 83 |
|
|
2023
Q2 | $94.9K | Hold |
5,860
| – | – | 0.07% | 65 |
|
|
2023
Q1 | $80.3K | Hold |
5,860
| – | – | 0.06% | 61 |
|
|
2022
Q4 | $59.7K | Hold |
5,860
| – | – | 0.05% | 51 |
|
|
2022
Q3 | $75K | Buy |
+5,860
| New | +$75K | 0.1% | 51 |
|